Guidance for Industry: Animal Drug User Fees and Fee Waivers and Reductions; Availability

Riepilogo

The Food and Drug Administration (FDA) is announcing the availability of a guidance document for industry ( 170) entitled "Animal Drug User Fees and Fee Waivers and Reductions." The purpose of this document is to provide guidance to industry on the fee waiver provisions of the Animal Drug User Fee Act of 2003 (ADUFA). The guidance document is immediately in effect, but it remains subject to comment in accordance with the agency's good guidance practices (GGPs).